A lot of companies talk about the quality of their talent; we are uniquely positioned with a team of full-time physicians and scientists leading our research and development efforts, including our Chief Medical Officer, Stephen Dahmer, M.D.
Steve and I met in Cuba while he was studying plant-based medicines, and he’s dedicated much of his professional life to advancing these causes. We have three other practicing physicians on our staff, as well as multiple scientists and engineers. Our Chief Science Officer, Eric Greenbaum, is an intellectual property lawyer in additional to his scientific expertise. We feel we’re very fortunate to have the team we’ve assembled, and believe that Vireo is engaged in exciting research and development opportunities. The team we’ve built allows Vireo to pursue scientific opportunities in a highly cost-effective manner that I don’t believe has been replicated in the cannabis space.
partners are nothing short of ideal whether be Ligand Pharmaceuticals , Park Nicolett, Northwell Health, mmj.org, Montefiore, University of Iowa, or the University of Minnesota …
and we already touched on the due diligence undertaken by the Cannabis Growth Opportunity Corporation. Am I missing any partners and from there … how critical is it to have a best in class team combined with industry leading partners?
140